Reuters logo
BRIEF-Cosmo Pharmaceuticals says Ferring's CORTIMENT MMX receives European approval
October 20, 2014 / 4:27 PM / 3 years ago

BRIEF-Cosmo Pharmaceuticals says Ferring's CORTIMENT MMX receives European approval

Oct 20 (Reuters) - Cosmo Pharmaceuticals SpA :

* Says Ferring’s CORTIMENT MMX, a new treatment for ulcerative colitis, receives European approval

* Says CORTIMENT MMX has received marketing approval from 27 European Union member states following EU mutual recognition procedure (MRP)

* Says Ferring plans to begin launching product in 27 additional European countries in coming months Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below